FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
-12.67%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$586M
AUM Growth
+$586M
(-25%)
Cap. Flow
-$69.1M
Cap. Flow
% of AUM
-11.8%
Top 10 Holdings %
Top 10 Hldgs %
50.11%
Holding
80
New
11
Increased
14
Reduced
24
Closed
16
Top Buys
| 1 |
CareDx
CDNA
|
$23.7M |
| 2 |
SPNE
SeaSpine Holdings Corporation Common Stock
SPNE
|
$21.8M |
| 3 |
PFNX
Pfenex Inc.
PFNX
|
$20.6M |
| 4 |
Iovance Biotherapeutics
IOVA
|
$15.9M |
| 5 |
United Therapeutics
UTHR
|
$12.2M |
Top Sells
| 1 |
Omnicell
OMCL
|
$37.1M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$24.1M |
| 3 |
MODN
MODEL N, INC.
MODN
|
$23M |
| 4 |
NeoGenomics
NEO
|
$20.1M |
| 5 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$19.3M |
Sector Composition
| 1 | Healthcare | 77.23% |
| 2 | Communication Services | 3.51% |
| 3 | Industrials | 1.19% |
| 4 | Energy | 0.34% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
KORU Medical Systems
KRMD
$195M
| $54.3M | 9.27% | 7,238,592 +20,578 | +0.3% | +$154K |
|
|
OXFD
2
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $37.5M | 6.4% | 4,050,040 -31,015 | -0.8% | -$287K |
|
|
SPNE
3
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $36.7M | 6.26% | 4,489,553 +2,663,149 | +146% | +$21.8M |
|
4
Halozyme
HALO
$8.56B
| $29.3M | 5.01% | 1,630,591 -70,191 | -4% | -$1.26M |
|
|
IMMU
5
DELISTED
Immunomedics Inc
IMMU
| $27.2M | 4.64% | 2,017,103 +771,860 | +62% | +$10.4M |
|
6
AtriCure
ATRC
$1.84B
| $25.2M | 4.31% | 750,818 -361,880 | -33% | -$12.2M |
|
|
7
CareDx
CDNA
$727M
| $23.7M | 4.05% | +1,085,752 | New | +$23.7M |
|
|
PFNX
8
DELISTED
Pfenex Inc.
PFNX
| $20.6M | 3.52% | +2,339,671 | New | +$20.6M |
|
|
MODN
9
DELISTED
MODEL N, INC.
MODN
| $20.6M | 3.51% | 925,921 -1,034,804 | -53% | -$23M |
|
10
Tandem Diabetes Care
TNDM
$845M
| $18.4M | 3.14% | 286,191 +17,617 | +7% | +$1.13M |
|
|
VAPO
11
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $17.5M | 2.99% | 930,092 -216,918 | -19% | -$4.08M |
|
|
XENT
12
DELISTED
Intersect ENT, Inc
XENT
| $17.2M | 2.94% | 1,453,729 +254,560 | +21% | +$3.02M |
|
13
iShares US Medical Devices ETF
IHI
$4.33B
| $17.1M | 2.92% | 7,580 | – | – |
|
|
14
NeoGenomics
NEO
$1.13B
| $16.9M | 2.88% | 610,664 -726,285 | -54% | -$20.1M |
|
15
Codexis
CDXS
$246M
| $16.6M | 2.83% | 1,486,598 +300,485 | +25% | +$3.35M |
|
16
Teva Pharmaceuticals
TEVA
$21.1B
| $16.6M | 2.83% | 1,843,246 +187,075 | +11% | +$1.68M |
|
17
Insmed
INSM
$28.8B
| $16.3M | 2.79% | 1,019,737 -273,811 | -21% | -$4.39M |
|
|
18
Iovance Biotherapeutics
IOVA
$807M
| $15.9M | 2.71% | +530,805 | New | +$15.9M |
|
19
Ultragenyx Pharmaceutical
RARE
$2.89B
| $15.2M | 2.6% | 342,603 +168,166 | +96% | +$7.47M |
|
|
20
United Therapeutics
UTHR
$13.8B
| $12.2M | 2.08% | +128,509 | New | +$12.2M |
|
|
ALXN
21
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $11M | 1.88% | 122,645 +96,361 | +367% | +$8.65M |
|
22
Ionis Pharmaceuticals
IONS
$6.79B
| $9.26M | 1.58% | 195,850 -47,841 | -20% | -$2.26M |
|
23
BioMarin Pharmaceuticals
BMRN
$11.2B
| $8.89M | 1.52% | 105,157 +3,647 | +4% | +$308K |
|
24
Heron Therapeutics
HRTX
$207M
| $8.12M | 1.39% | 691,400 -389,759 | -36% | -$4.58M |
|
25
SI-BONE Inc
SIBN
$719M
| $8.11M | 1.38% | 678,773 -6,358 | -0.9% | -$76K |
|